Clearmind Medicine Return on Equity (ROE) Growth & History (CMND)
Clearmind Medicine's return on equity was −179.39% for fiscal 2025.
View full Clearmind Medicine company overviewClearmind Medicine annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-10-31 | −179.39% | +77.50 pp |
| 2024 | 2024-10-31 | −256.89% | — |
| 2022 | 2022-10-31 | −571.69% | −426.43 pp |
| 2021 | 2021-10-31 | −145.26% | — |
Clearmind Medicine quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-04-30 | −20.76% | +9.66 pp |
| Q1 2026 | 2026-01-31 | −81.74% | −45.79 pp |
| Q4 2025 | 2025-10-31 | −60.92% | −34.03 pp |
| Q3 2025 | 2025-07-31 | −78.02% | −26.44 pp |
| Q2 2025 | 2025-04-30 | −30.41% | +1.85 pp |
| Q1 2025 | 2025-01-31 | −35.95% | — |
| Q4 2024 | 2024-10-31 | −26.89% | — |
| Q3 2024 | 2024-07-31 | −51.58% | — |
| Q2 2024 | 2024-04-30 | −32.27% | +153.45 pp |
| Q2 2023 | 2023-04-30 | −185.72% | — |
Clearmind Medicine return on equity trends
Between the periods ended 2021-10-31 and 2025-10-31, Clearmind Medicine's return on equity decreased from −145.26% to −179.39%, a change of −34.13 percentage points. The latest reported quarter, Q2 2026, shows −20.76%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Clearmind Medicine source filings ↗